155 related articles for article (PubMed ID: 15723614)
1. Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy.
Kuan CY; Burke RE
Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):63-7. PubMed ID: 15723614
[TBL] [Abstract][Full Text] [Related]
2. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.
Silva RM; Kuan CY; Rakic P; Burke RE
Mov Disord; 2005 Jun; 20(6):653-64. PubMed ID: 15719422
[TBL] [Abstract][Full Text] [Related]
3. Coupling between neuronal nitric oxide synthase and glutamate receptor 6-mediated c-Jun N-terminal kinase signaling pathway via S-nitrosylation contributes to ischemia neuronal death.
Yu HM; Xu J; Li C; Zhou C; Zhang F; Han D; Zhang GY
Neuroscience; 2008 Sep; 155(4):1120-32. PubMed ID: 18676085
[TBL] [Abstract][Full Text] [Related]
4. Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition.
Bessero AC; Chiodini F; Rungger-Brändle E; Bonny C; Clarke PG
J Neurochem; 2010 Jun; 113(5):1307-18. PubMed ID: 20345748
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons.
Harris CA; Deshmukh M; Tsui-Pierchala B; Maroney AC; Johnson EM
J Neurosci; 2002 Jan; 22(1):103-13. PubMed ID: 11756493
[TBL] [Abstract][Full Text] [Related]
6. JNK signalling: a possible target to prevent neurodegeneration.
Borsello T; Forloni G
Curr Pharm Des; 2007; 13(18):1875-86. PubMed ID: 17584114
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways.
Ito S; Ozawa K; Zhao J; Kyotani Y; Nagayama K; Yoshizumi M
J Pharmacol Sci; 2015 Jan; 127(1):69-74. PubMed ID: 25704021
[TBL] [Abstract][Full Text] [Related]
8. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
9. JNK inhibition as a potential strategy in treating Parkinson's disease.
Wang W; Ma C; Mao Z; Li M
Drug News Perspect; 2004 Dec; 17(10):646-54. PubMed ID: 15696229
[TBL] [Abstract][Full Text] [Related]
10. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease.
Peng J; Andersen JK
IUBMB Life; 2003; 55(4-5):267-71. PubMed ID: 12880208
[TBL] [Abstract][Full Text] [Related]
11. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids.
Onyango IG; Tuttle JB; Bennett JP
Mol Cell Neurosci; 2005 Mar; 28(3):452-61. PubMed ID: 15737736
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
13. Targeting the JNK pathway for therapeutic benefit in CNS disease.
Bozyczko-Coyne D; Saporito MS; Hudkins RL
Curr Drug Targets CNS Neurol Disord; 2002 Feb; 1(1):31-49. PubMed ID: 12769633
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway.
Gao Y; Signore AP; Yin W; Cao G; Yin XM; Sun F; Luo Y; Graham SH; Chen J
J Cereb Blood Flow Metab; 2005 Jun; 25(6):694-712. PubMed ID: 15716857
[TBL] [Abstract][Full Text] [Related]
15. A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption.
Müller GJ; Geist MA; Veng LM; Willesen MG; Johansen FF; Leist M; Vaudano E
J Neurochem; 2006 Mar; 96(5):1242-52. PubMed ID: 16478524
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways.
Liu Y; Song Y; Zhu X
Med Sci Monit; 2017 Apr; 23():1597-1606. PubMed ID: 28365714
[TBL] [Abstract][Full Text] [Related]
17. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss.
Wang J; Van De Water TR; Bonny C; de Ribaupierre F; Puel JL; Zine A
J Neurosci; 2003 Sep; 23(24):8596-607. PubMed ID: 13679429
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells.
Min YK; Park JH; Chong SA; Kim YS; Ahn YS; Seo JT; Bae YS; Chung KC
J Neurosci Res; 2003 Mar; 71(5):689-700. PubMed ID: 12584727
[TBL] [Abstract][Full Text] [Related]
19. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Ye Q; Yuan X; Zhou J; Yuan C; Yang X
J Tradit Chin Med; 2017 Apr; 37(2):244-51. PubMed ID: 29960635
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
Aikin R; Maysinger D; Rosenberg L
Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
